News
February 14, 2019
Safety of Long term use of Hydroxychloroquine Therapy Further Verified for People with Lupus
Hydroxychloroquine (Plaquenil®) was approved by the Food and Drug Administration for symptoms of lupus. The greatest concern people with lupus have when taking hydroxychloroquine is related to vision and an increase in risk for retinal damage. A new investigation analyzed the retinal changes over a five-year period in people with lupus and did not find clinically relevant retinal changes in the group. The study concludes that hydroxychloroquine therapy is safe for long-term use at doses <5 mg/kg/day. Learn about how lupus affects the eyes and hydroxychloroquine.
See More:
The latest from Inside Lupus Research
News
Differences in Disease Activity by Onset-Age in People with Systemic Lupus Erythematosus
News
Neighborhood Disadvantage Associated with Lower Testing and Physician Access in Young People with Systemic Lupus Erythematosus Despite Insurance Coverage
News
Study Reveals Depression is Often Undiagnosed in People with Systemic Lupus Erythematosus
News
Drug Update: First Person Dosed with Investigational Therapy AlloNK for Lupus Nephritis